Myeloproliferative Neoplasm Stem Cells

As the understanding of the molecular mechanisms underlying the clonal dominance of myeloproliferative neoplasms stem cells advances, this will help facilitate the development of therapies that preferentially target myeloproliferative neoplasms stem cells over normal hematopoietic stem cells.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.